Hiroyuki Mizuguchi Selected Research

Luciferases

1/2013	NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites.
8/2012	Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy.
1/2010	Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.
3/2002	Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Mizuguchi Research Topics

Disease

76	Neoplasms (Cancer) 06/2022 - 02/2002
22	Infections 01/2022 - 12/2002
14	Hypersensitivity (Allergy) 01/2022 - 04/2007
11	Seasonal Allergic Rhinitis (Hay Fever) 01/2022 - 12/2008
10	Allergic Rhinitis 02/2021 - 12/2008
9	Melanoma (Melanoma, Malignant) 01/2018 - 03/2002
7	Inflammation (Inflammations) 01/2020 - 05/2003
6	Circulating Neoplastic Cells 05/2018 - 10/2009
4	Virus Diseases (Viral Diseases) 04/2022 - 12/2002
4	Insulin Resistance 04/2022 - 05/2003
4	Communicable Diseases (Infectious Diseases) 02/2022 - 05/2003
4	Drug-Related Side Effects and Adverse Reactions 09/2021 - 01/2012
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 05/2003
4	Liver Diseases (Liver Disease) 01/2018 - 02/2011
4	Carcinoma (Carcinomatosis) 01/2010 - 06/2005
3	Neoplasm Metastasis (Metastasis) 06/2022 - 07/2007
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2006
3	Colitis 01/2020 - 05/2003
3	Sneezing 01/2018 - 12/2008
2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 07/2017
2	Teratoma (Teratoid Tumor) 03/2021 - 12/2017
2	Atopic Dermatitis (Atopic Eczema) 02/2021 - 09/2018
2	Coinfection 01/2021 - 08/2004
2	Brain Edema (Cerebral Edema) 01/2021 - 01/2020
2	Chemical and Drug Induced Liver Injury 01/2019 - 02/2017
2	Lung Neoplasms (Lung Cancer) 05/2018 - 01/2010
2	Hemophilia B (Haemophilia B) 01/2018 - 09/2017
2	Liver Failure 01/2017 - 05/2016
2	Hypoxia (Hypoxemia) 12/2016 - 05/2015
2	Malignant Mesothelioma 01/2013 - 08/2011
2	type 2C Congenital disorder of glycosylation 01/2013 - 08/2008
2	Lymphatic Metastasis 06/2010 - 10/2006
2	Necrosis 03/2010 - 04/2002

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2002
14	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2022 - 07/2005
13	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 04/2007
13	Messenger RNA (mRNA)IBA 01/2022 - 06/2008
11	Histamine H1 Receptors (Histamine H1 Receptor)IBA 02/2021 - 04/2010
10	CytokinesIBA 01/2020 - 03/2002
9	Histamine Antagonists (Antihistamines)IBA 01/2022 - 09/2008
9	adenovirus receptorIBA 03/2021 - 03/2002
7	Thymidine KinaseIBA 09/2011 - 03/2002
6	VaccinesIBA 02/2022 - 01/2005
6	Pharmaceutical PreparationsIBA 01/2019 - 02/2011
6	Peptides (Polypeptides)IBA 01/2017 - 04/2003
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2009
5	Neutralizing AntibodiesIBA 01/2021 - 06/2004
5	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2010
5	InterleukinsIBA 01/2018 - 03/2002
5	Interleukin-4 (Interleukin 4)IBA 01/2017 - 04/2003
5	AntigensIBA 05/2014 - 05/2003
5	Therapeutic UsesIBA 04/2012 - 03/2002
5	Interleukin-12 (IL 12)IBA 11/2008 - 12/2003
5	ChemokinesIBA 11/2008 - 08/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007 - 03/2002
5	arginyl-glycyl-aspartic acidIBA 06/2005 - 03/2002
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2006
4	Biological ProductsIBA 12/2021 - 07/2007
4	CathepsinsIBA 05/2021 - 01/2015
4	AntibodiesIBA 01/2018 - 01/2010
4	LuciferasesIBA 01/2013 - 03/2002
4	IntegrinsIBA 08/2012 - 04/2002
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2011 - 09/2007
4	Ganciclovir (Cytovene)FDA LinkGeneric 10/2008 - 03/2002
3	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 02/2004
3	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2022 - 10/2015
3	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2021 - 05/2015
3	Interleukin-9 (Interleukin 9)IBA 01/2020 - 01/2018
3	Capsid Proteins (Capsid Protein)IBA 03/2019 - 01/2015
3	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 09/2018 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 11/2012
3	ErbB Receptors (EGF Receptor)IBA 12/2016 - 03/2004
3	LigandsIBA 06/2010 - 05/2003
2	Caspase 3 (Caspase-3)IBA 12/2021 - 12/2016
2	InterferonsIBA 01/2021 - 01/2015
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 05/2014
2	Interleukin-33IBA 01/2018 - 04/2012
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2018 - 09/2017
2	Glutamine (L-Glutamine)FDA Link 01/2018 - 02/2004
2	TolueneIBA 01/2018 - 03/2009
2	Indicators and Reagents (Reagents)IBA 05/2017 - 09/2012
2	Epithelial Cell Adhesion MoleculeIBA 05/2017 - 09/2011
2	adenovirus associated RNA (VA RNA)IBA 01/2017 - 01/2017
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2016 - 05/2003
2	Histidine DecarboxylaseIBA 04/2016 - 06/2008
2	Dextrans (Dextran)FDA Link 01/2015 - 05/2003
2	LipidsIBA 05/2014 - 08/2008
2	Immunoglobulin E (IgE)IBA 01/2013 - 08/2008
2	EnzymesIBA 09/2011 - 07/2005
2	Small Interfering RNA (siRNA)IBA 07/2011 - 08/2004
2	ClaudinsIBA 06/2010 - 01/2006

Therapy/Procedure

27	Therapeutics 01/2022 - 05/2003
7	Immunotherapy 07/2011 - 04/2004
4	Transplantation 03/2021 - 05/2016
3	Phototherapy (Light Therapy) 02/2021 - 01/2016
3	Liver Transplantation 01/2020 - 03/2010
2	Lasers (Laser) 08/2017 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2013 - 09/2009